RT @PeterKolchinsky: As a a virologist, I’m reassured by data out of China showing that a fairly basic vaccine protected monkeys from SARS2…
RT @PeterKolchinsky: As a a virologist, I’m reassured by data out of China showing that a fairly basic vaccine protected monkeys from SARS2…
As a a virologist, I’m reassured by data out of China showing that a fairly basic vaccine protected monkeys from SARS2 #COVID19-like disease. While this was likely result, details are important- they didn’t see “enhancement”, which many feared. https://t.c
RT @Aiims1742: Sinovac (China) has a preprint out on an inactivated #SARSCoV2 #vaccine (PiCoVacc) that partially or completely protected a…
RT @Aiims1742: Sinovac (China) has a preprint out on an inactivated #SARSCoV2 #vaccine (PiCoVacc) that partially or completely protected a…
Rapid development of an inactivated vaccine for SARS-CoV-2 | bioRxiv https://t.co/GSE6yri28f
Researchers in Beijing report #COVIDー19 vax (traditional purified inactivated virus)--> antibodies neutralized 10 strains, protected macaques vs. viral challenge. No safety issues. If it works & is 1st to market, will #AmericaFirst be met w/ 'China
RT @KrishRoyLab: Important vaccine preprint for #COVID19. Quick look Pros: NHP study, potential protection against multuple strains, conven…
Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/VUJqW4ZYzR
preprint on a Chinese inactivated vaccine in animals looks fine-ish? https://t.co/qgoLODzbAb one detail that seems a little weird — virus was still able to replicate pretty well in the nose, which suggests vaccinated infected people might still be contagio
RT @KrishRoyLab: Important vaccine preprint for #COVID19. Quick look Pros: NHP study, potential protection against multuple strains, conven…
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
RT @hemofelo: Rapid development of an inactivated SARS-CoV-2 vaccine. Needs to enter human trials urgently. #COVID https://t.co/DSXl8kGiKi
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
First vaccine published with enough detailed information, well behaved in safety. It’s reported that there are more than 100 vaccine under study. It’s not the time to compete but share all we obtained. https://t.co/FDiEOnuzJT
Perhaps.... Who really trusts these guys?
RT @Aiims1742: Sinovac (China) has a preprint out on an inactivated #SARSCoV2 #vaccine (PiCoVacc) that partially or completely protected a…
Contribute a rapid review or request one for "Rapid development of an inactivated vaccine for SARS-CoV-2" (https://t.co/Pq9MNlG5gO). "Add" or "Request" w/DOI (10.1101/2020.04.17.046375) at https://t.co/RnurTL3DyM @outbreaksci @PREreview_
New #SARSCoV preprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/Pq9MNlG5gO
RT @Aiims1742: Sinovac (China) has a preprint out on an inactivated #SARSCoV2 #vaccine (PiCoVacc) that partially or completely protected a…
@BengtHojer Kineserna kan vara ett vaccin på spåren. De kan kanske ta bra betalt för det. https://t.co/HTpqQGK1Zh
Important vaccine preprint for #COVID19. Quick look Pros: NHP study, potential protection against multuple strains, conventional established strategy. Cons: 3 doses, virus challenge too early in my opinion, IT challenge, short follow up, no T cell changes?
https://t.co/1qn8xW8xmt Rapid development of an inactivated vaccine for SARS-CoV-2 Pilot-scale production of a purified inactivated SARS-CoV-2 virus vaccine candidate (PiCoVacc), which induced SARS-CoV-2-specific neutralizing antibodies in mice, rats an
RT @hemofelo: Rapid development of an inactivated SARS-CoV-2 vaccine. Needs to enter human trials urgently. #COVID https://t.co/DSXl8kGiKi
Rapid development of an inactivated SARS-CoV-2 vaccine. Needs to enter human trials urgently. #COVID https://t.co/DSXl8kGiKi
Wonderful news! https://t.co/udj2XBDfFe
@AndyBiotech Here's SinoVac preprint of their #covid19 PicoVacc vaccine (some weird results, poor charts rendering quality, human data in Fig 2b ??? or was it NHP?) Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/2w6abHYvG4
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
Rapid development of an inactivated #vaccine for SARS-CoV-2 | bioRxiv https://t.co/kVuSNC6LCL
Vaccine for SARS-CoV-2. Good news! https://t.co/V3JAlIn1V6
bioRxiv viewer https://t.co/MMOihJtcwL Traditional effort to generate vaccine identified potential candidate, strain inactivated w/β-propiolactone. Caused antibodies, esp targeting RBD, in mice and macaques. Primates protected from challenge infections. Bo
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
Rhesus macaques successfully vaccinated (with inactivated virus) against SARS-CoV-2, with no observable side-effects (pre-print): https://t.co/m6ppIupWeu - human trials later this year.
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
RT @genomematt: Reasonably promising signs for the more traditional style of vaccine development. The recombinant vaccines would probably b…
RT @Aiims1742: Sinovac (China) has a preprint out on an inactivated #SARSCoV2 #vaccine (PiCoVacc) that partially or completely protected a…
Considering our current urgency, I am particularly excited and hopeful for the sucess of innactivated Sars-Cov-2 vaccine trials! Excelent work!
Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/uYZzBRileq Animal data looks promising
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
RT @Aiims1742: Sinovac (China) has a preprint out on an inactivated #SARSCoV2 #vaccine (PiCoVacc) that partially or completely protected a…
RT @iskander: Reading: "Rapid development of an inactivated vaccine for SARS-CoV-2" https://t.co/uJDoRNU6bu
RT @iskander: Reading: "Rapid development of an inactivated vaccine for SARS-CoV-2" https://t.co/uJDoRNU6bu
RT @iskander: Reading: "Rapid development of an inactivated vaccine for SARS-CoV-2" https://t.co/uJDoRNU6bu
RT @iskander: Reading: "Rapid development of an inactivated vaccine for SARS-CoV-2" https://t.co/uJDoRNU6bu
RT @iskander: Reading: "Rapid development of an inactivated vaccine for SARS-CoV-2" https://t.co/uJDoRNU6bu
RT @Aiims1742: Sinovac (China) has a preprint out on an inactivated #SARSCoV2 #vaccine (PiCoVacc) that partially or completely protected a…
Highly potent and broad inactivated vaccine with 6ug dose that is able to confer complete protection against viral challenge in macaques. No ADE and other safety concerns.
Looks like another #SARSCoV2 vaccine candidate will be moving into #clinicaltrials - SinoVac reported in @biorxivpreprint (WARNING #NOTpeerReviewed) animal data inducing NAbs without ADE #COVID19 https://t.co/s90Xjv4wFH
RT @Aiims1742: Sinovac (China) has a preprint out on an inactivated #SARSCoV2 #vaccine (PiCoVacc) that partially or completely protected a…
Reading: "Rapid development of an inactivated vaccine for SARS-CoV-2" https://t.co/uJDoRNU6bu
Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/0me3HNCn7F
Rapid development of an inactivated vaccine for SARS-CoV-2 | bioRxiv https://t.co/zpAQpwYHjm
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
RT @Aiims1742: Sinovac (China) has a preprint out on an inactivated #SARSCoV2 #vaccine (PiCoVacc) that partially or completely protected a…
RT @Aiims1742: Sinovac (China) has a preprint out on an inactivated #SARSCoV2 #vaccine (PiCoVacc) that partially or completely protected a…
RT @Aiims1742: Sinovac (China) has a preprint out on an inactivated #SARSCoV2 #vaccine (PiCoVacc) that partially or completely protected a…
RT @Aiims1742: Sinovac (China) has a preprint out on an inactivated #SARSCoV2 #vaccine (PiCoVacc) that partially or completely protected a…
Rapid development of an inactivated vaccine for SARS-CoV-2 | bioRxiv https://t.co/N5R5CMpucX
Sinovac (China) has a preprint out on an inactivated #SARSCoV2 #vaccine (PiCoVacc) that partially or completely protected against viral challenge in macaques (pulmonary histopathology included). Still a long path forward but encouraging data. https://t.c
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
Reasonably promising signs for the more traditional style of vaccine development. The recombinant vaccines would probably be used in preference (fewer antigens so potentially better safety profile), but good to see the alternatives progressing
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
RT @biorxivpreprint: Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv
Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/g4WKSBbfk5 #biorxiv_micrbio
Rapid development of an inactivated vaccine for SARS-CoV-2 https://t.co/fnXgnrPkW1 #bioRxiv